Objectives: The goal of this article is to report the successful treatment of a patient with complex regional pain syndrome (CRPS) type 1 involving the hand with the use of an intravenous regional block.
C omplex regional pain syndrome (CRPS) is a syndrome characterized by pain (eg, burning pain, allodynia, hyperpathia), sensory disorder (hyposensitive or hypersensitive), swelling, contracture, sweating disorder (excessive sweating or diminished sweating), color change, and so forth. [1] [2] [3] [4] The syndrome can occur after blunt trauma, fracture, medical treatments (eg, operation, drip infusion, injection, percutaneous examination), and so forth. 1, [5] [6] [7] Several theories 1, [8] [9] [10] exist to explain the occurrence and development of this syndrome, which is often extremely difficult to treat.
In some cases, contracture occurs and passive movement is often essential to improve range of motion (ROM). Patients with a severe contracture need more intensive passive movement, which can exacerbate the pain and increase the disability. Intravenous regional blocks with lidocaine have been used in patients with a long duration of severe contracture to reduce pain during passive movement. This article describes an approach for managing patients with refractory CRPS.
CASE REPORT
A right-handed 35-year-old woman sustained a fifth metacarpal fracture in a traffic accident. The fracture was casted for 3 weeks. Approximately 3 weeks after the accident, she felt pain in the right hand while still in the cast. Upon removal of the cast, she was noted to have swelling, decreased ROM of the fingers and wrist, and pain in the right hand. Over the next year she received active ROM exercise, contrast baths, loxoprofen sodium, Neurotropin 11, 12 (16 Neurotropin units per day), and a hand brace to keep the wrist joint extended without intravenous regional block. These treatments reduced the pain only moderately and did not restore function. She developed significant insomnia and anxiety, which resulted in a 2-week psychiatric hospitalization 13 months after the accident. She responded to antipsychotic medication and was discharged.
Two months later she was admitted to Hiroshima University Hospital for treatment of her CRPS. At the time of admission she had hypoesthesia, hypoalgesia, and hyperpathia of the right hand (palm and dorsum). Severe spontaneous pain was reported as 10/10 (VAS) but no allodynia was present. Moderate right-hand edema was present (Fig. 1A) . The hand was almost nonfunctional because of severe contractures and pain (Table 1) . Twenty-five medications, including zotepine, biperiden, carbamazepine, bromazepam, and propericyazine, had been prescribed. While taking these medications, she was drowsy during the daytime. Multimodal rehabilitation, including intravenous regional block with lidocaine (IRB-L), was performed.
The IRB-L was administered through a plastic intravenous catheter or needle inserted into a vein on the dorsum of the affected hand or wrist. An infusion with saline was started in the healthy upper limb before the block to prepare for dizziness after the tourniquet was deflated. After exsanguination with an elastic bandage from the wrist to the upper arm, one of two pneumatic tourniquets was inflated in the upper arm. The two tourniquets were inflated one after the other. The usual dose was a maximum of 30 mL of 0.5 mL/kg of 1% lidocaine without epinephrine that was slowly injected through the catheter or needle. For the first block, two thirds of usual dose was used. The dose was adjusted based on the patient's report of dizziness after deflation of tourniquet and pain during manipulation. The duration of the exsanguination was 40 to 50 minutes. After the limb was anesthetized, all affected joints were manipulated in a progressive, controlled fashion without undue force. At the end of the treatment, the tourniquet was deflated for 60 seconds at a time to minimize the possibility of a systemic reaction to the unfixed portion of lidocaine. The first five blocks were given twice per week and then once per week for a total of 10 blocks, all on an outpatient basis. This patient weighed approximately 70 kg and was injected with 20 to 24 mL of 1% lidocaine to decrease dizziness after deflation of the tourniquet. Betamethasone was not used in this case because of a past history of steroid-induced delirium.
She continued her other therapies, including contrast baths, irradiation near the stellate ganglion with linear polarized nearinfrared light (Superlizer, commonly used in Japan), 13 transcutaneous electrical nerve stimulation, active movement, and passive movement, all without her usual pain. She also increased her Neurotropin dosage to 24 units per day. In this patient, treatment was successful in reducing symptoms and improving function (Table 1) . She was discharged from the hospital 3 months later with no pain (0/10) at rest and being able to perform active hand movements. Her edema resolved (see Fig. 1B ) and she could use a pen, a pair of chopsticks, and a hammer with the right hand, and her grip strength was 6.5 kg. At discharge her medications for pain were vastly decreased and she returned to normal cognitive level.
DISCUSSION
The patient described in this article was one of our most complex and difficult-to-treat patients, presenting with a psychiatric diagnosis that resulted in profound behavioral changes in addition to her CRPS. However, the regional treatments appear to have allowed improvement in the hand movement and tolerance to other rehabilitation efforts that helped restore function. Although the symptoms were not completely relieved, the patient and her family reported satisfaction with the results. While it is true that all treatments contributed to the results, we believe that the IRB-L improved the patient's ability to perform active movement, which had not been possible with her previous treatment.
In general, the overall ROM gradually improved after every treatment through the tenth block. ROM improved during and immediately after administration of the block but gradually worsened again as the block wore off. Repeated blocks were essential in this patient with chronic and severe symptoms. The use of two pneumatic or elastic bandage tourniquets appeared to alleviate binding regional pain, which made prolonged manipulation possible, improving overall ROM.
As for side effects, the transient dizziness that can occur in about half the patients after release of the tourniquet was a problem in this patient but was relieved by slightly reducing the dose. The symptoms were transient and would disappear in 15 minutes. Ten blocks is a common number, but the number of blocks will depend on the patient.
To put this case in perspective (Table 2) , HanningtonKiff 14 first reported the use of intravenous regional block with guanethidine for the treatment of CRPS but did not manipulate the limb during the block. Poplawski et al 15 reported intravenous regional block with methylprednisolone (Solu-Medrol) and lidocaine for the treatment of posttraumatic dystrophy. Tountas and Noguchi 16 and Zyluk 17 performed a similar intravenous regional block with methylprednisolone and lidocaine for the treatment of CRPS. Kose et al reported that CRPS type 1 of the upper limb with swelling is an indication for intravenous regional block, based on their results. 18 We used the treatment timing of Kose's plan, 18, 19 but without use of betamethasone, and we adjusted the lidocaine as described. If the symptoms had been completely relieved before 10 blocks were given, 10 blocks would not have been necessary. The Bier block with lidocaine is mainly used as anesthesia for operations and has been a safe procedure [20] [21] [22] when the tourniquet is kept on for at least 20 minutes. 15, 23 We have used intravenous regional block with either betamethasone and lidocaine or lidocaine alone, including in patients without CRPS, more than 200 times. Kose did intravenous regional block with either betamethasone and lidocaine more than 1,000 times. 19 Our treatment of this patient with CRPS supports the consideration of IRB-L to relieve painful manipulation and physical therapy. When used carefully it can be done safely and is usually well tolerated by patients. It may be an effective adjuvant for patients with CRPS type 1 of the upper limb and can be considered in patients who do not respond to other therapies. 
